3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 3
1
Status
Recruiting
2
Completed
1
Sponsor Class
INDUSTRY
8
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Gastrointestinal
3
Conditions
Colorectal Neoplasms
70
Rectal Neoplasms
28
Colonic Neoplasms
28
Carcinoma, Hepatocellular
26
Neoplasm Metastasis
15
Stomach Neoplasms
12
Pancreatic Neoplasms
7
Cholangiocarcinoma
6
Adenocarcinoma Of Esophagus
6
Esophageal Neoplasms
5
Recurrence
4
Liver Neoplasms
4
Biliary Tract Neoplasms
4
Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Peritoneal Neoplasms
2
Neoplastic Cells, Circulating
2
Gastrointestinal Neoplasms
2
Colorectal Cancer Metastatic
2
Cirrhosis, Familial, with Pulmonary Hypertension
2
Adenocarcinoma
2
Postoperative Complications
1
Peripheral Nervous System Diseases
1
Pathologic Complete Response
1
Pancreatic Adenocarcinoma
1
Operable T2-3N+M0 Rectal Cancer (Stage III)
1
Oligometastatic Gastric Adenocarcinoma
1
Neurotoxicity Syndromes
1
Neuropathy, Painful
1
Neuralgia
1
Interventions
Surveys and Questionnaires
114
Exercise
103
Blood Specimen Collection
99
Radiotherapy
66
Gemcitabine
64
Bevacizumab
57
Standard of Care
56
Cisplatin
55
Cyclophosphamide
51
Capecitabine
50
Carboplatin
49
Docetaxel
47
pembrolizumab
46
Dexamethasone
46
Paclitaxel
45
Interviews as Topic
43
Oxaliplatin
40
Magnetic Resonance Spectroscopy
39
Fluorouracil
37
Methods
36
Irinotecan
36
Therapeutics
33
Drug Therapy
32
Radiosurgery
31
Nivolumab
30
Erlotinib Hydrochloride
27
Educational Status
26
Everolimus
24
Leucovorin
23
Control Groups
23
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
OTHER
×
Neoplasms
×
Folfox protocol
×
Clear all
NCT06846346
2026-04-28
GRACIE
UNICANCER
Phase 2
Recruiting
88 enrolled
NCT06475352
2026-04-23
FUDOSE
UNICANCER
Phase 2
Recruiting
400 enrolled
NCT02967289
2025-11-17
IROCAS
UNICANCER
Phase 3
Completed
792 enrolled